SEARCH

SEARCH BY CITATION

References

  • ABBRACCHIO, M.P., BOEYNAEMS, J.M., BARNARD, E.A., BOYER, J.L., KENNEDY, C., MIRAS-PORTUGAL, M.T., KING, B.F., GACHET, C., JACOBSON, K.A., WEISMAN, G.A. & BURNSTOCK, G. (2003). Characterization of the UDP-glucose receptor (re-named here the P2Y14 receptor) adds diversity to the P2Y receptor family. Trends Pharmacol. Sci., 24, 5255.
  • ABRAMS, P., CARDOZO, L., FALL, M., GRIFFITHS, D., ROSIER, P., ULMSTEN, U., VAN KERREBROECK, P., VICTOR, A. & WEIN, A. (2002). The standardisation of terminology of lower urinary tract function: report from the standardisation sub-committee of the International Continence Society. Neurourol. Urodyn., 21, 167178.
  • ANDERSSON, K.E. (1993). Pharmacology of lower urinary tract smooth muscles and penile erectile tissues. Pharmacol. Rev., 45, 253308.
  • ANDERSSON, K.E. & WEIN, A. (2004). Pharmacology of the lower urinary tract: basis for current and future treatments of urinary incontinence. Pharmacol. Rev., 56, 581631.
  • BARCLAY, J., PATEL, S., DORN, G., WOTHERSPOON, G., MOFFATT, S., EUNSON, L., ABDEL'AL, S., NATT, F., HALL, J., WINTER, J., BEVAN, S., WISHART, W., FOX, A. & GANJU, P. (2002). Functional downregulation of P2X3 receptor subunit in rat sensory neurons reveals a significant role in chronic neuropathic and inflammatory pain. J. Neurosci., 22, 81398147.
  • BAYLISS, M., WU, C., NEWGREEN, D., MUNDY, A.R. & FRY, C.H. (1999). A quantitative study of atropine-resistant contractile responses in human detrusor smooth muscle, from stable, unstable and obstructed bladders. J. Urol., 162, 18331839.
  • BIRDER, L.A., BARRICK, S.R., ROPPOLO, J.R., KANAI, A.J., DE GROAT, W.C., KISS, S. & BUFFINGTON, C.A. (2003). Feline interstitial cystitis results in mechanical hypersensitivity and altered ATP release from bladder urothelium. Am. J. Physiol. (Renal Physiol.), 285, F423F429.
  • BIRDER, L.A., NAKAMURA, Y., KISS, S., NEALEN, M.L., BARRICK, S., KANAI, A.J., WANG, E., RUIZ, G., DE GROAT, W.C., APODACA, G., WATKINS, S. & CATERINA, M.J. (2002). Altered urinary bladder function in mice lacking the vanilloid receptor TRPV1. Nat. Neurosci., 5, 856860.
  • BIRDER, L.A., RUAN, H.Z., CHOPRA, B., XIANG, Z., BARRICK, S., BUFFINGTON, C.A., ROPPOLO, J.R., FORD, A.P.D.W., DE GROAT, W.C. & BURNSTOCK, G. (2004). Alterations in P2X and P2Y purinergic receptor expression in urinary bladder from normal cats and cats with interstitial cystitis. Am. J. Physiol. (Renal Physiol.), 287, F1084F1091.
  • BLEEHEN, T., HOBBIGER, F. & KEELE, C.A. (1976). Identification of algogenic substances in human erythrocytes. J. Physiol., 262, 131149.
  • BLEEHEN, T. & KEELE, C.A. (1977). Observations on the algogenic actions of adenosine compounds on the human skin blister base preparation. Pain, 3, 367377.
  • BRADBURY, E.J., BURNSTOCK, G. & MCMAHON, S.B. (1998). The expression of P2X3 purinoreceptors in sensory neurons: effects of axotomy and glial-derived neurotrophic factor. Mol. Cell. Neurosci., 12, 256268.
  • BRADING, A.F. & WILLIAMS, J.H. (1990). Contractile responses of smooth muscle strips from rat and guinea-pig urinary bladder to transmural stimulation: effects of atropine and alpha, beta-methylene ATP. Br. J. Pharmacol., 99, 493498.
  • BRADY, C.M., APOSTOLIDIS, A., YIANGOU, Y., BAECKER, P.A., FORD, A.P., FREEMAN, A., JACQUES, T.S., FOWLER, C.J. & ANAND, P. (2004). P2X3-immunoreactive nerve fibres in neurogenic detrusor overactivity and the effect of intravesical resiniferatoxin. Eur. Urol., 46, 247253.
  • BRAZ, J.M., NASSAR, M.A., WOOD, J.N. & BASBAUM, A.I. (2005). Parallel ‘pain’ pathways arise from subpopulations of primary afferent nociceptor. Neuron, 47, 787793.
  • BURNSTOCK, G. (1972). Purinergic nerves. Pharmacol. Rev., 24, 509581.
  • BURNSTOCK, G. (2000). Purinergic signalling in lower urinary tract. In: Handbook of Experimental Pharmacology, ed. Abbracchio, M.P. & Williams, M. pp. 423515. Berlin: Springer Verlag.
  • BURNSTOCK, G. (2001). Purine-mediated signalling in pain and visceral perception. Trends Pharmacol. Sci., 22, 182188.
  • BURNSTOCK, G., COCKS, T., CROWE, R. & KASAKOV, L. (1978). Purinergic innervation of the guinea-pig urinary bladder. Br. J. Pharmacol., 63, 125138.
  • CADDLE, M., BERG, C. & SZNEKE, P. (2003). Benign prostatic hyperplasia. September 2003, Decision Resources Mosaic Study #39. Waltham, Mass.: Decision Resources.
  • CARDOZO, L., LISEC, M., MILLARD, R., VAN VIERSSEN TRIP, O., KUZMIN, I., DROGENDIJK, T.E., HUANG, M. & RIDDER, A.M. (2004). Randomized, double-blind placebo controlled trial of the once daily antimuscarinic agent solifenacin succinate in patients with overactive bladder. J. Urol., 172, 19191924.
  • CHANCELLOR, M.B., KAPLAN, S.A. & BLAIVAS, J.G. (1992). The cholinergic and purinergic components of detrusor contractility in a whole rabbit bladder model. J. Urol., 148, 906909.
  • CHAPPLE, C., STEERS, W., NORTON, P., MILLARD, R., KRALIDIS, G., GLAVIND, K. & ABRAMS, P. (2005). A pooled analysis of three phase III studies to investigate the efficacy, tolerability and safety of darifenacin, a muscarinic M3 selective receptor antagonist, in the treatment of overactive bladder. BJU Int., 95, 9931001.
  • CHAPPLE, C.R. (2000). Muscarinic receptor antagonists in the treatment of overactive bladder. Urology, 55, 3346.
  • CHAPPLE, C.R., RECHBERGER, T., AL SHUKRI, S., MEFFAN, P., EVERAERT, K., HUANG, M. & RIDDER, A. (2004). Randomized, double-blind placebo- and tolterodine-controlled trial of the once-daily antimuscarinic agent solifenacin in patients with symptomatic overactive bladder. BJU Int., 93, 303310.
  • CHAPPLE, C.R. & SMITH, D. (1994). The pathophysiological changes in the bladder obstructed by benign prostatic hyperplasia. Br. J. Urol., 73, 117123.
  • CLEMENS, J.Q., MEEHAN, R.T., ROSETTI, M.C., GAO, S.Y. & CALHOUN, E.A. (2005). Prevalence and incidence of interstitial cystitis in a managed care population. J. Urol., 173, 98102.
  • COCKAYNE, D.A., DUNN, P.M., ZHONG, Y., RONG, W., HAMILTON, S.G., KNIGHT, G.E., RUAN, H.Z., MA, B., YIP, P., NUNN, P., MCMAHON, S.B., BURNSTOCK, G. & FORD, A.P.D.W. (2005). P2X2 knockout mice and P2X2/P2X3 double knockout mice reveal a role for the P2X2 receptor subunit in mediating multiple sensory effects of ATP. J. Physiol., 567, 621639.
  • COCKAYNE, D.A., HAMILTON, S.G., ZHU, Q.-M., DUNN, P.M., ZHONG, Y., NOVAKOVIC, S., MALMBERG, A.B., CAIN, G., BERSON, A., KASSOTAKIS, L., HEDLEY, L., LACHNIT, W.G., BURNSTOCK, G., MCMAHON, S.B. & FORD, A.P.D.W. (2000). Urinary bladder hyporeflexia and reduced pain-related behavior in P2X3-deficient mice. Nature, 407, 10111015.
  • COLLIER, H.O., JAMES, G.W. & SCHNEIDER, C. (1966). Antagonism by aspirin and fenamates of bronchoconstriction and nociception induced by adenosine-5′-triphosphate. Nature, 212, 411412.
  • COVA, R., GUARNERI, L., ANGELICO, P., VELASCO, C., LEONARDI, A. & TESTA, R. (1999). Effects of infravesical suramin and PPADS on cystometrographic parameters in conscious rats. Urodinamica, 9, 162168.
  • COWAN, W.D. & DANIEL, E.E. (1983). Human female bladder and its noncholinergic contractile function. Can J. Physiol. Pharmacol., 61, 12361246.
  • DANG, K., BIELEFELDT, K. & GEBHART, G.F. (2005a). Differential responses of bladder lumbosacral and thoracolumbar dorsal root ganglion neurons to purinergic agonists, protons, and capsaicin. J. Neurosci., 25, 39733984.
  • DANG, K., BURNES, L., KARDOS, S., BIELEFELDT, K. & GEBHART, G.F. (2005b). Cyclophosphamide-induced bladder inflammation enhances P2X receptor function and sensitizes rat lumbosacral and thoracolumbar dorsal root ganglion neurons. Program No. 170.2. 2005 Abstract Viewer/Itinerary Planner. 35th Annual Meeting of the Society for Neuroscience. Washington, DC, November 12–16, 2005.
  • DEAN, D.M. & DOWNIE, J.W. (1978). Contribution of adrenergic and ‘purinergic’ neurotransmission to contraction in rabbit detrusor. J. Pharmacol. Exp. Ther., 207, 431445.
  • DE GROAT, W.C., ARAKI, I., VIZZARD, M.A., YOSHIYAMA, M., YOSHIMURA, N., SUGAYA, K., TAI, C. & ROPPOLO, J.R. (1998). Developmental and injury induced plasticity in the micturition reflex pathway. Behav. Brain Res., 92, 127140.
  • DE GROAT, W.C., DOWNIE, J.W., LEVIN, R.M., LIN, A.T.L., MORRISON, J.F.B., NISHIZAWA, O., STEERS, W.D. & THOR, K.B. (1999). Basic neurophysiology and neuropharmacology. In: Incontinence: 1st International Consultation on Incontinence, June 28–July 1, 1998, Monaco, ed. Abrams, P., Khoury, S. & Wein, A. pp. 105154. St Helier, Jersey, UK: Health Publication.
  • DORN, G., PATEL, S., WOTHERSPOON, G., HEMMINGS-MIESZCZAK, M., BARCLAY, J., NATT, F.J.C., MARTIN, P., BEVAN, S., FOX, A., GANJU, P., WISHART, W. & HALL, J. (2004). siRNA relieves chronic neuropathic pain. Nucleic Acids Res., 32, e49.
  • DUNN, P.M., ZHONG, Y. & BURNSTOCK, G. (2001). P2X receptors in peripheral neurons. Prog. Neurobiol., 65, 107134.
  • EGAN, K.J. & KRIEGER, J.L. (1997). Chronic abacterial prostatitis – a urological chronic pain syndrome Pain, 69, 213218.
  • ELNEIL, S., SKEPPER, J.N., KIDD, E.J., WILLIAMSON, J.G. & FERGUSON, D.R. (2001). Distribution of P2X(1) and P2X(3) receptors in the rat and human urinary bladder. Pharmacology, 63, 120128.
  • FABIAN, M.A., BIGGS, W.H., TREIBER, D.K., ATTERIDGE, C.E., AZIMIOARA, M.D., BENEDETTI, M.G., CARTER, T.A., CICERI, P., EDEEN, P.T., FLOYD, M., FORD, J.M., GALVIN, M., GERLACH, J.L., GROTZFELD, R.M., HERRGARD, S., INSKO, D.E., INSKO, M.A., LAI, A.G., LELIAS, J.M., MEHTA, S.A., MILANOV, Z.V., VELASCO, A.M., WODICKA, L.M., PATEL, H.K., ZARRINKAR, P.P. & LOCKHART, D.J. (2005). A small molecule-kinase interaction map for clinical kinase inhibitors. Nat. Biotech., 23, 329336.
  • FERGUSON, D.R., KENNEDY, I. & BURTON, T.J. (1997). ATP is released from rabbit urinary bladder epithelial cells by hydrostatic pressure changes – a possible sensory mechanism J. Physiol., 505, 503511.
  • FERNANDES, D. & COCOROS, N. (2005). Urge urinary incontinence. August 2005, Decision Resources Mosaic Study #1. Waltham, Mass: Decision Resources.
  • FOWLER, C.J. (2000). Intravesical treatment of overactive bladder. Urology, 55, 6064.
  • FRY, C.H., SKENNERTON, D., WOOD, D. & WU, C. (2002). The cellular basis of contraction in human detrusor smooth muscle from patients with stable and unstable bladders. Urology, 59, 312.
  • FUJII, K. (1988). Evidence for adenosine triphosphate as an excitatory transmitter in guinea-pig, rabbit and pig urinary bladder. J. Physiol., 404, 3952.
  • GEVER, J.R., PADILLA, F., KNIGHT, G.F., DUNN, P.M., TRAN, A., MANDEL, D.A., HEGDE, S.S., JIAME-FIGUEROA, S., GREENHOUSE, R.J., LACHNIT, W.G., BURNSTOCK, G. & FORD, A.P.D.W. (2004). In vitro and in vivo characterization of RO0437626, a novel and selective P2X1 antagonist. On Purines 2004: 4th International Symposium on Nucleosides and Nucleotides. Chapel Hill, NC, June 6–9 2004, p. 86.
  • GU, J.G. & MACDERMOTT, A.B. (1997). Activation of ATP P2X receptors elicits glutamate release from sensory neuron synapses. Nature, 389, 749753.
  • HAAB, F. & CASTRO-DIAZ, D. (2005). Persistence with antimuscarinic therapy in patients with overactive bladder. Int. J. Clin. Prac., 59, 931937.
  • HAAB, F., STEWART, L. & DWYER, P. (2004). Darifenacin, an M3 selective receptor antagonist, is an effective and well-tolerated once-daily treatment for overactive bladder. Eur. Urol., 45, 420429.
  • HABLER, H.J., JANIG, W. & KOLTZENBURG, M. (1990). Activation of unmyelinated afferent fibres by mechanical stimuli and inflammation of the urinary bladder in the cat. J. Physiol., 425, 545562.
  • HABLER, H.J., JANIG, W. & KOLTZENBURG, M. (1993). Myelinated primary afferents of the sacral spinal cord responding to slow filling and distension of the cat urinary bladder. J. Physiol., 463, 449460.
  • HAMILTON, S.G., WARBURTON, J., BHATTACHARJEE, A., WARD, J. & MCMAHON, S.B. (2000). ATP in human skin elicits a dose related pain response which is potentiated under conditions of hyperalgesia. Brain, 123, 12381246.
  • HANSEN, M.A., BALCAR, V.J., BARDEN, J.A. & BENNETT, M.R. (1998). The distribution of single P2x1-receptor clusters on smooth muscle cells in relation to nerve varicosities in the rat urinary bladder. J. Neurocytol., 27, 529539.
  • HARVEY, R. (2002). The contractile potency of adenosine triphosphate and ecto-adenosine triphosphatase activity in guinea pig detrusor and detrusor from patients with a stable, unstable or obstructed bladder. J. Urol., 168, 12351239.
  • HEGDE, S.S., MANDEL, D.A., WILFORD, M.R., BRIAUD, S., FORD, A.P.D.W. & EGLEN, R.M. (1998). Evidence for purinergic neurotransmission in the urinary bladder of pithed rats. Eur. J. Pharmacol., 349, 7582.
  • HERBISON, P., HAY-SMITH, J., ELLIS, G. & MOORE, K. (2003). Effectiveness of anticholinergic drugs compared with placebo in the treatment of overactive bladder: systematic review. Br. Med. J., 326, 841844.
  • HILLIGES, M., WEIDNER, C., SCHMELZ, M., SCHMIDT, R., ORSTAVIK, K., TOREBJORK, E. & HANDWERKER, H. (2002). ATP responses in human C nociceptors. Pain, 98, 5968.
  • HOLTON, P. (1959). The liberation of adenosine triphosphate on antidromic stimulation of sensory nerves. J. Physiol., 145, 494504.
  • HONORE, P., KAGE, K., MIKUSA, J., WATT, A.T., JOHNSTON, J.F., WYATT, J.R., FALTYNEK, C.R., JARVIS, M.F. & LYNCH, K. (2002a). Analgesic profile of intrathecal P2X3 antisense oligonucleotide treatment in chronic inflammatory and neuropathic pain states in rats. Pain, 99, 1119.
  • HONORE, P., MIKUSA, J., BIANCHI, B., MCDONALD, H., CARTMELL, J., FALTYNEK, C. & JARVIS, M.F. (2002b). TNP-ATP, a potent P2X3 receptor antagonist, blocks acetic acid-induced abdominal constriction in mice: comparison with reference analgesics. Pain, 96, 99105.
  • HOURANI, S.M. & CHOWN, J.A. (1989). The effects of some possible inhibitors of ectonucleotidases on the breakdown and pharmacological effects of ATP in the guinea-pig urinary bladder. Gen. Pharmacol., 20, 413416.
  • HOYLE, C.H.V. & BURNSTOCK, G. (1985). Atropine-resistant excitatory junction potentials in rabbit bladder are blocked by α,β-methylene ATP. Eur. J. Pharmacol., 114, 239240.
  • IGAWA, Y., MATTIASSON, A. & ANDERSSON, K.-E. (1993). Functional importance of cholinergic and purinergic neurotransmission for micturition contraction in the normal, unanaesthetized rat. Br. J. Pharmacol., 109, 473479.
  • INOUE, K., TSUDA, M. & KOIZUMI, S. (2003). ATP induced three types of pain behaviors, including allodynia. Drug Dev. Res., 59, 5663.
  • INOUE, R. & BRADING, A.F. (1990). The properties of the ATP-induced depolarization and current in single cells isolated from the guinea-pig urinary bladder. Br. J. Pharmacol., 100, 619625.
  • INOUE, R. & BRADING, A.F. (1991). Human, pig and guinea-pig bladder smooth muscle cell generate similar inward currents in response to purinoceptor activation. Br. J. Pharmacol., 103, 18401841.
  • JACOBSON, K.A., COSTANZI, S., OHNO, M., JOSHI, B.V., BESADA, P., XU, B. & TCHILIBON, S. (2004). Molecular recognition at purine and pyrimidine nucleotide (P2) receptors. Curr. Topics Med. Chem., 4, 805819.
  • JAIME-FIGUEROA, S., GREENHOUSE, R., PADILLA, F., DILLON, M.P., GEVER, J.R. & FORD, A.P.D.W. (2005). Discovery and synthesis of a novel and selective drug-like P2X1 antagonist. Bioorg. Med. Chem. Lett., 15, 32923295.
  • JARVIS, M.F., BURGARD, E.C., MCGARAUGHTY, S., HONORE, P., LYNCH, K., BRENNAN, T.J., SUBIETA, A., VAN BIESEN, T., CARTMELL, J., BIANCHI, B., NIFORATOS, W., KAGE, K., YU, H., MIKUSA, J., WISMER, C.T., ZHU, C.Z., CHU, K., LEE, C.H., STEWART, A.O., POLAKOWSKI, J., COX, B.F., KOWALUK, E., WILLIAMS, M., SULLIVAN, J. & FALTYNEK, C. (2002). A-317491, a novel potent and selective non-nucleotide antagonist of P2X3 and P2X2/3 receptors, reduces chronic inflammatory and neuropathic pain in the rat. Proc. Nat. Acad. Sci. U.S.A., 99, 1717917184.
  • JARVIS, M.F., WISMER, C.T., SCHWEITZER, E., YU, H., VAN BIESEN, T., LYNCH, K.J., BURGARD, E.C. & KOWALUK, E.A. (2001). Modulation of BzATP and formalin induced nociception: attenuation by the P2X receptor antagonist, TNP-ATP and enhancement by the P2X3 allosteric modulator, cibacron blue. Br. J. Pharmacol., 132, 259269.
  • JARVIS, M.J. (2003). Contributions of P2X3 homomeric and heteromeric channels to acute and chronic pain. Exp. Opin. Ther. Targets, 7, 513522.
  • JONES, C.A. & NYBERG, L.M. (1997). Epidemiology of interstitial cystitis. Urology, 49, 29.
  • KASAKOV, L. & BURNSTOCK, G. (1983). The use of the slowly degradable analog, α,β-methylene ATP, to produce desensitisation of the P2-purinoceptor: effect on non-adrenergic, non-cholinergic responses of the guinea-pig urinary bladder. Eur. J. Pharmacol., 86, 291294.
  • KHERA, M., SOMOGYI, G.T., KISS, S., BOONE, T.B. & SMITH, C.P. (2004). Botulinum toxin A inhibits ATP release from bladder urothelium after chronic spinal cord injury. Neurochem. Int., 45, 987993.
  • KINDER, R.B. & MUNDY, A.R. (1985). Atropine blockade of nerve-mediated stimulation of the human detrusor. Br. J. Urol., 57, 418421.
  • KING, B.F., KNOWLES, I.D., BURNSTOCK, G. & RAMAGE, A.G. (2004). Investigation of the effects of P2 purinoceptor ligands on the micturition reflex in female urethane-anaesthetized rats. Br. J. Pharmacol., 142, 519530.
  • KING, J.A., HUDDART, H. & STAFF, W.G. (1997). Purinergic modulation of rat urinary bladder detrusor smooth muscle. Gen. Pharmacol., 29, 597604.
  • KREAM, R.M. & CARR, D.B. (1999). Interstitial cystitis. A complex visceral pain syndrome Focus: Pain Forum, 8, 139145.
  • KRIEGER, J.N., RILEY, D.E., CHEAH, P.Y., LIONG, M.L. & YUEN, K.H. (2003). Epidemiology of prostatitis: new evidence for a world-wide problem. World J. Urol., 21, 7074.
  • LECCI, A. & MAGGI, C.A. (2005). Overactive urinary bladder: targeting sensory pathways. Drug Disc. Today: Ther. Strat., 2, 1523.
  • LEE, H.Y., BRADINI, M. & BURNSTOCK, G. (2000). Distribution of P2X receptors in the urinary bladder and the ureter of the rat. J. Urol., 163, 20022007.
  • LEVIN, R.M., LONGHURST, P.A., KATO, K., MCGUIRE, E.J., ELBADAWI, A. & WEIN, A.J. (1990). Comparative physiology and pharmacology of the cat and rabbit urinary bladder. J. Urol., 143, 848852.
  • LEVIN, R.M. & WEIN, A.J. (1982). Response of the in vitro whole bladder (rabbit) preparation to autonomic agonists. J. Urol., 128, 10871090.
  • LIEU, P.K., SA'ADU, A., ORUGUN, E.O. & MALONE-LEE, J.G. (1997). The influence of age on isometric and isotonic rat detrusor contractions. J. Gerontol.: Med. Sci., 52, M94M96.
  • LIPINSKI, C.A., LOMBARDO, F., DOMINY, B.W. & FEENEY, P.J. (2001). Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Delivery Rev., 46, 326.
  • LU, S., FRASER, M., CHANCELLOR, M., SUN, L. & DE GROAT, W.C. (2002). Evaluation of voiding dysfunction and purinergic mechanism in awake long-term spinal cord injured rats: comparison of metabolism cage and cystometrogram measurements. J. Urol., 167, 276.
  • MASUDA, H., CHANCELLOR, M., KIHARA, K., DE GROAT, W. & YOSHIMURA, N. (2005). Evidence for the involvement of spinal endogenous ATP and P2X receptors in detrusor overactivity caused by acetic acid, acrolein or cyclophosphamide. 35th Annual Meeting of the International Continence Society, Montreal, Canada, August 28–September 2, 2005.
  • MCGARAUGHTY, S., WISMER, C.T., ZHU, C.Z., MIKUSA, J., HONORE, P., CHU, K.L., LEE, C.H., FALTYNEK, C.R. & JARVIS, M.F. (2003). Effects of A-317491, a novel and selective P2X3/P2X2/3 receptor antagonist, on neuropathic, inflammatory and chemogenic nociception following intrathecal and intraplantar administration. Br. J. Pharmacol., 140, 13811388.
  • MICHEL, M.C., OELKE, M. & ZINNER, N. (2005). Novel muscarinic antagonists to treat incontinence and/or overactive bladder. Drug Disc. Today: Ther. Strat., 2, 16.
  • MILANI, S. & DJAVAN, B. (2005). Lower urinary tract symptoms suggestive of benign prostatic hyperplasia: latest update on α1-adrenoceptor antagonists. BJU Int., 95, 2936.
  • MITSUI, T., KAKIZAKI, H., MATSUURA, S., AMEDA, K., YOSHIOKA, M. & KOYANAGI, T. (2001). Afferent fibers of the hypogastric nerves are involved in the facilitating effects of chemical bladder irritation in rats. J. Neurophysiol., 86, 22762284.
  • MORK, H., ASHINA, M., BENDTSEN, L., OLESEN, J. & JENSEN, R. (2003). Experimental muscle pain and tenderness following infusion of endogenous substances in humans. Eur. J. Pain, 7, 145153.
  • MUZZONIGRO, G. (2005). Tamsulosin in the treatment of LUTS/BPH: an Italian multicentre trial. Arch. Ital. Urol. Androl., 77, 1317.
  • NAKATSUKA, T. & GU, J.G. (2001). ATP P2X receptor-mediated enhancement of glutamate release and evoked EPSCs in dorsal horn neurons of the rat spinal cord. J. Neurosci., 21, 65226531.
  • NAKATSUKA, T., TSUZUKI, K., LING, J.X., SONOBE, H. & GU, J.G. (2003). Distinct roles of P2X receptors in modulating glutamate release at different primary sensory synapses in rat spinal cord. J. Neurophysiol., 89, 32433252.
  • NAMASIVAYAM, S., EARDLEY, I. & MORRISON, J.F.B. (1999). Purinergic sensory neurotransmission in the urinary bladder: an in vitro study in the rat. Br. J. Urol. Int., 84, 854860.
  • NERGARDH, A. & KINN, A.C. (1983). Neurotransmission in activation of the contractile response in the human urinary bladder. Scand. J. Urol. Nephrol., 17, 153157.
  • NICKE, A., BAEUMERT, H.G., RETTINGER, J., EICHELE, A., LAMBRECHT, G., MUTSCHLER, E. & SCHMALZING, G. (1998). P2X1 and P2X3 receptors form stable trimers: a novel structural motif of ligand-gated ion channels. EMBO J., 17, 30163028.
  • NICKEL, J.C. (2003). Recommendations for the evaluation of patients with prostatitis. World J. Urol., 21, 7581.
  • NISHIGUCHI, J., SASAKI, K., SEKI, S., CHANCELLOR, M.B., ERICKSON, K.A., DE GROAT, W.C., KUMON, H. & YOSHIMURA, N. (2004). Effects of isolectin B4-conjugated saporin, a targeting cytotoxin, on bladder overactivity induced by bladder irritation. Eur. J. Neurosci., 20, 474482.
  • NORTH, R.A. (2002). Molecular physiology of P2X receptors. Physiol. Rev., 82, 10131067.
  • NUNN, P.A. & NEWGREEN, D.T. (1999). An investigation into the bladder responses induced via pelvic nerve stimulation in the anesthetized rat. Br. J. Pharmacol., 126, 227P.
  • O'REILLY, B.A., KOSAKA, A.H., CHANG, T.K., FORD, A.P.D.W., POPERT, R., RYMER, J.M. & MCMAHON, S.B. (2001). A quantitative analysis of purinoceptor expression in human fetal and adult bladders. J. Urol., 165, 17301734.
  • O'REILLY, B.A., KOSAKA, A.H., KNIGHT, G.F., CHANG, T.K., FORD, A.P.D.W., RYMER, J.M., POPERT, R., BURNSTOCK, G. & MCMAHON, S.B. (2002). P2X receptors and their role in female idiopathic detrusor instability. J. Urol., 167, 157164.
  • PALEA, S., ARTIBANI, W., OSTARDO, E., TRIST, D.G. & PIETRA, C. (1993). Evidence for purinergic neurotransmission in human urinary bladder affected by interstitial cyctitis. J. Urol., 150, 20072012.
  • PANDITA, R.K. & ANDERSSON, K.-E. (2002). Intravesical adenosine triphosphate stimulates the micturition reflex in awake, freely moving rats. J. Urol., 168, 12301234.
  • REITZ, A., STOHRER, M., KRAMER, G., DEL POPOLO, G., CHARTIER-KASTLER, E., PANNEK, J., BURGDORFER, H., GOCKING, K., MADERSBACHER, H., SCHUMACHER, S., RICHTER, R., VON TOBEL, J. & CHURCH, B. (2004). European experience of 200 cases treated with botulinum-A toxin injections into the detrusor muscle for urinary incontinence due to neurogenic detrusor overactivity. Eur. Urol., 45, 510515.
  • RONG, W., SPYER, K.M. & BURNSTOCK, G. (2002). Activation and sensitisation of low and high threshold afferent fibres mediated by P2X receptors in the mouse urinary bladder. J. Physiol., 541, 591600.
  • SALAS, N.A., SMITH, C.P., KISS, S., BOONE, T.B. & SOMOGYI, G.T. (2005). Intravesical cholinergic receptor activated spinal ATP release in normal and chronic spinal cord injured rats. J. Urol., 173, 45.
  • SCHAEFFER, A.J. (2003). Epidemiology and demographics of prostatitis. Andrologia, 35, 252257.
  • SIBLEY, G.N. (1984). A comparison of spontaneous and nerve-mediated activity in bladder muscle from man, pig and rabbit. J. Physiol., 354, 431443.
  • SJOGREN, C., ANDERSSON, K.-E., HUSTED, S., MATTIASSON, A. & MOLLER-MADSEN, B. (1982). Atropine resistance of transmurally stimulated isolated human bladder muscle. J. Urol., 128, 13681371.
  • SMITH, C.P., RADZISZEWSKI, P., BORKOWSKI, A., SOMOGYI, G.T., BOONE, T.B. & CHANCELLOR, M.B. (2004). Botulinum toxin A has antinociceptive effects in treating interstitial cystitis. Urology, 64, 871875.
  • SMITH, C.P., VEMULAKONDA, V.M., KISS, S., BOONE, T.B. & SOMOGYI, G.T. (2005). Enhanced ATP release from rat bladder urothelium during chronic bladder inflammation: Effect of botulinum toxin A. Neurochem. Int., 47, 291297.
  • SOUSLOVA, V., CESARE, P., DING, Y., AKOPIAN, A.N., STANFA, L., SUZUKI, R., CARPENTER, K., DICKENSON, A., BOYCE, S., HILL, R., NEBENIUS-OOSTHUIZEN, D., SMITH, A.J.H., KIDD, E.J. & WOOD, J.N. (2000). Warm-coding deficits and aberrant inflammatory pain in mice lacking P2X3 receptors. Nature, 407, 10151017.
  • SPEAKMAN, M.J., KIRBY, R.S., JOYCE, A., ABRAMS, P. & POCOCK, R. (2004). Guideline for the primary care management of male lower urinary tract symptoms. BJU Int., 93, 985990.
  • SUN, Y. & CHAI, T.C. (2002). Effects of dimethyl sulphoxide and heparin on stretch-activated ATP release by bladder urothelial cells from patients with interstitial cystitis. BJU Int., 90, 381385.
  • SUN, Y. & CHAI, T.C. (2004). Up-regulation of P2X3 receptor during stretch of bladder urothelial cells from patients with interstitial cystitis. J. Urol., 171, 448452.
  • SUN, Y., KEAY, S., DEDEYNE, P.G. & CHAI, T.C. (2001). Augmented stretch activated adenosine triphosphate release from bladder uroepithelial cells in patients with interstitial cystitis. J. Urol., 166, 19511956.
  • SUN, Y., MALOSSI, J., JACOBS, S.C. & CHAI, T.C. (2002). Effect of doxazosin on stretch-activated adenosine triphosphate release in bladder urothelial cells from patients with benign prostatic hyperplasia. Urology, 60, 351356.
  • TONG, Y.C., HUNG, Y.C., SHINOZUKA, K., KUNITOMO, M. & CHENG, J.T. (1997). Evidence of adenosine 5′-triphosphate release from nerve and P2x-purinoceptor mediated contraction during electrical stimulation of rat urinary bladder smooth muscle. J. Urol., 158, 19731977.
  • TSUDA, M., UENO, S. & INOUE, K. (1999a). Evidence for the involvement of spinal endogenous ATP and P2X receptors in nociceptive responses caused by formalin and capsaicin in mice. Br. J. Pharmacol., 128, 14971504.
  • TSUDA, M., UENO, S. & INOUE, K. (1999b). In vivo pathway of thermal hyperalgesia by intrathecal administration of α,β-methylene ATP in mouse spinal cord: involvement of the glutamate-NMDA receptor system. Br. J. Pharmacol., 127, 449456.
  • UENO, S., MORIYAMA, T., HONDA, K., KAMIYA, H., SAKURADA, T. & KATSURAGI, T. (2003). Involvement of P2X2 and P2X3 receptors in neuropathic pain in a mouse model of chronic constriction injury. Drug Dev. Res., 59, 104111.
  • VELASCO, C., GUARNERI, L., LEONARDI, A. & TESTA, R. (2003). Effects of intravenous and infravesical administration of suramin, terazosin and BMY 7378 on bladder instability in conscious rats with bladder outlet obstruction. BJU Int., 92, 131136.
  • VIAL, C. & EVANS, R.J. (2000). P2X receptor expression in mouse urinary bladder and the requirement of P2X1 receptors for functional P2X receptor responses in the mouse urinary bladder smooth muscle. Br. J. Pharmacol., 131, 14891495.
  • VIAL, C. & EVANS, R.J. (2001). Smooth muscle does not have a common P2X receptor phenotype: expression, ontogeny and function of P2X1 receptors in mouse ileum, bladder and reproductive systems. Auton. Neurosci. Basic Clin., 92, 5664.
  • VLASKOVSKA, M., KASAKOV, L., RONG, W., BODIN, P., BARDINI, M., COCKAYNE, D.A., FORD, A.P.D.W. & BURNSTOCK, G. (2001). P2X3 knock-out mice reveal a major sensory role for urothelially released ATP. J. Neurosci., 21, 56705677.
  • VULCHANOVA, L., RIEDL, M.S., SHUSTER, S.J., BUELL, G., SURPRENANT, A., NORTH, R.A. & ELDE, R. (1997). Immunohistochemical study of the P2X2 and P2X3 receptor subunits in rat and monkey sensory neurons and their central terminals. Neuropharmacology, 36, 12291242.
  • VULCHANOVA, L., RIEDL, M.S., SHUSTER, S.J., STONE, L.S., HARGREAVES, K.M., BUELL, G., SURPRENANT, A., NORTH, R.A. & ELDE, R. (1998). P2X3 is expressed by DRG neurons that terminate in inner lamina II. Eur. J. Neurosci., 10, 34703478.
  • WANG, E.C.Y., LEE, J.M., RUIZ, W.G., BALESTREIRE, E.M., VON BODUNGEN, M., BARRICK, S., COCKAYNE, D.A., BIRDER, L.A. & APODACA, G. (2005). ATP and purinergic receptor-dependent membrane traffic in bladder umbrella cells. J. Clin. Inves., 115, 24122422.
  • WEIN, A.J. (2001). Pharmacological agents for the treatment of urinary incontinence due to overactive bladder. Expert Opin. Inves. Drugs, 10, 6583.
  • WEIN, A.J. & HANNO, P.M. (2002). Targets for therapy of the painful bladder. Urology, 59, 6873.
  • WESTFALL, T.D., KENNEDY, C. & SNEDDON, P. (1997). The ecto-ATPase inhibitor ARL 67156 enhances parasympathetic neurotransmission in the guinea-pig urinary bladder. Eur. J. Pharmacol., 329, 169173.
  • WU, C. (1999). A comparison of the mode of action of ATP and carbachol on isolated human detrusor smooth muscle. J. Urol., 162, 1840.
  • WU, G., WHITESIDE, G.T., LEE, G., NOLAN, S., NIOSI, M., PEARSON, M.S. & ILYIN, V.I. (2004). A-317491, a selective P2X3/P2X2/3 receptor antagonist, reverses inflammatory mechanical hyperalgesia through action at peripheral receptors in rats. Eur. J. Pharmacol., 504, 4553.
  • WUST, M., AVERBECK, B., REIF, S., BRATER, M. & RAVENS, U. (2002). Different responses to drugs against overactive bladder in detrusor muscle of pig, guinea pig and mouse. Eur. J. Pharmacol., 454, 5969.
  • YIANGOU, Y., FACER, P., FORD, A., BRADY, C., WISEMAN, O., FOWLER, C.J. & ANAND, P. (2001). Capsaicin receptor VR1 and ATP-gated ion channel P2X3 in human urinary bladder. BJU Int., 87, 774779.
  • YOSHIDA, M., HOMMA, Y., INADOME, A., YONO, M., SESHITA, H., MIYAMOTO, Y., MURAKAMI, S., KAWABE, K. & UEDA, S. (2001). Age-related changes in cholinergic and purinergic neurotransmission in human isolated bladder smooth muscle. Exp. Gerontol., 36, 99109.
  • YOSHIDA, M., MIYAMAE, K., IWASHITA, H., OTANI, M. & INADOME, A. (2004). Management of detrusor dysfunction in the elderly: changes in acetylcholine and adenosine triphosphate release during aging. Urology, 63, 1723.
  • YOSHIMURA, N. & DE GROAT, W.C. (1999). Increased excitability of afferent neurons innervating rat urinary bladder after chronic bladder inflammation. J. Neurosci., 19, 46444653.
  • YOSHIMURA, N., SEKI, S., CHANCELLOR, M.B., DE GROAT, W.C. & UEDA, T. (2002). Targeting afferent hyperexcitability for therapy of the painful bladder syndrome. Urology, 59, 6167.
  • YOSHIMURA, N., SEKI, S., ERICKSON, K.A., ERICKSON, V.L., CHANCELLOR, M.B. & DE GROAT, W.C. (2003). Histological and electrical properties of rat dorsal root ganglion neurons innervating the lower urinary tract. J. Neurosci., 23, 43554361.
  • ZERMANN, D.H., ISHIGOOKA, M., SCHUBERT, J. & SCHMIDT, R.A. (2000). Perisphincteric injection of botulinum toxin type A. Eur. Urol., 38, 393399.
  • ZHONG, Y., BANNING, A.S., COCKAYNE, D.A., FORD, A.P.D.W., BURNSTOCK, G. & MCMAHON, S.B. (2003). Bladder and cutaneous sensory neurons of the rat express different functional P2X receptors. Neuroscience, 120, 667675.
  • ZIGANSHIN, A.U., HOYLE, C.H., BO, X., LAMBRECHT, G., MUTSCHLER, E., BAUMERT, H.G. & BURNSTOCK, G. (1993). PPADS selectively antagonizes P2X-purinoceptor-mediated responses in the rabbit urinary bladder. Br. J. Pharmacol., 110, 14911495.